Catalio Capital Management, LP
Top Portfolio Positions
41 positions ·
$478,705,573 total
· as of Mar 31, 2026
| Ticker | Company | Shares | Value (USD) | % of Portfolio | Open |
|---|---|---|---|---|---|
| DNTH |
Dianthus Therapeutics, Inc. /DE/
Healthcare
|
560,308 | $47,021,047 | 9.82% | |
| BBIO |
BridgeBio Pharma, Inc.
Healthcare
|
432,014 | $32,081,359 | 6.70% | |
| ASND |
Ascendis Pharma A/S
Healthcare
|
129,111 | $29,531,559 | 6.17% | |
| BMY |
Bristol Myers Squibb Co
Healthcare
|
420,727 | $25,517,092 | 5.33% | |
| SNDX |
Syndax Pharmaceuticals Inc
Healthcare
|
1,043,670 | $24,380,131 | 5.09% | |
| GILD |
Gilead Sciences, Inc.
Healthcare
|
163,905 | $22,843,439 | 4.77% | |
| TERN |
Terns Pharmaceuticals, Inc.
Healthcare
|
409,031 | $21,564,114 | 4.50% | |
| DFTX |
Definium Therapeutics, Inc.
Healthcare
|
1,037,984 | $19,617,897 | 4.10% | |
| SLNO |
Soleno Therapeutics Inc
Healthcare
|
577,808 | $19,345,011 | 4.04% | |
| BSX |
Boston Scientific Corp
Healthcare
|
299,318 | $18,782,204 | 3.92% |
Portfolio Trend
6 quarters · across all stocks
Holdings in BBIO
Shares Held
Position Value (USD)
5 quarters on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $32,081,359 | 432,014 | Shares | Sole | 2026-05-15 | |
| 2025-09-30 | $32,344,544 | 622,729 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $40,058,560 | 927,711 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $33,286,865 | 962,883 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $24,653,687 | 898,458 | Shares | Sole | 2025-02-14 | |
| No 13F history on record for this holder in this stock. | ||||||